{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:46:30Z","timestamp":1775216790855,"version":"3.50.1"},"reference-count":45,"publisher":"Galenos Yayinevi","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"published-print":{"date-parts":[[2023,12,25]]},"DOI":"10.4274\/tjps.galenos.2023.68054","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T08:44:49Z","timestamp":1699951489000},"page":"0-0","source":"Crossref","is-referenced-by-count":3,"title":["Development of Cyclosporine A Nanosuspension using Experimental Design by Response Surface Methodology: In Vitro Evaluations"],"prefix":"10.4274","volume":"0","author":[{"given":"S\u0131la","family":"G\u00fclba\u011f P\u0131nar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevin","family":"\u00c7elebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2023,12,25]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12247-020-09530-5","article-title":"Particle size reduction techniques of pharmaceutical compounds for the enhancement of their dissolution rate and bioavailability","volume":"17","author":"Kumar","year":"2022","unstructured":"1. Kumar R, Thakur AK, Chaudhari P, Banerjee N. Particle size reduction techniques of pharmaceutical compounds for the enhancement of their dissolution rate and bioavailability. J Pharm Innov 2022;17:333-352.","journal-title":"J Pharm Innov"},{"key":"ref1","unstructured":"2. Borel JF, Kis ZL. The discovery and development of cyclosporine (Sandimmune). Transplant Proc. 1991;23:1867-1874."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jconrel.2016.01.056","article-title":"Reformulating cyclosporine A (CsA): More than just a life cycle management strategy","volume":"225","author":"Guada","year":"2016","unstructured":"3. Guada M, Beloqui A, Kumar MN, Pr\u00e9at V, Dios-Vi\u00e9itez Mdel C, Blanco-Prieto MJ. Reformulating cyclosporine A (CsA): More than just a life cycle management strategy. J Control Release. 2016;225:269-282.","journal-title":"J Control Release"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.biotechadv.2011.03.004","article-title":"Cyclosporin A--a review on fermentative production, downstream processing and pharmacological applications","volume":"29","author":"Survase","year":"2011","unstructured":"4. Survase SA, Kagliwal LD, Annapure US, Singhal RS. Cyclosporin A--a review on fermentative production, downstream processing and pharmacological applications. Biotechnol Adv. 2011;29:418-435.","journal-title":"Biotechnol Adv"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Wenger RM, Payne TG, Schreier MH. Cyclosporine: chemistry, structure activity relationships and mode of action. Anonymous metabolic control in diabetes mellitus beta adrenoceptor blocking drugs nmr analysis of cancer cells \u0131mmunoassay in the clinical laboratory cyclosporine. Springer. 1986;157-191.","DOI":"10.1007\/978-3-642-70998-2_5"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/03639040601155665","article-title":"Cyclosporine A: a review of current oral and intravenous delivery systems","volume":"33","author":"Beauchesne","year":"2007","unstructured":"6. Beauchesne PR, Chung NS, Wasan KM. Cyclosporine A: a review of current oral and intravenous delivery systems. Drug Dev Ind Pharm. 2007;33:211-220.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","unstructured":"7. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413-420.","journal-title":"Pharm Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.35333\/jrp.2019.65","article-title":"Optimization and evaluation of cyclosporine A nanosuspension stabilized by combination stabilizers using high pressure homogenization method","volume":"23","author":"G\u00fclba\u011f P\u0131nar","year":"2019","unstructured":"8. G\u00fclba\u011f P\u0131nar S, \u00c7elebi N. Optimization and evaluation of cyclosporine A nanosuspension stabilized by combination stabilizers using high pressure homogenization method. J Res Pharm. 2019;23:1009-1021.","journal-title":"J Res Pharm"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"101577","DOI":"10.1016\/j.jddst.2020.101577","article-title":"Design of self-dispersible microsponge containing cyclosporine through wet milling and drop freeze-drying processes to improve dissolution behavior","volume":"57","author":"Kobayashi","year":"2020","unstructured":"9. Kobayashi M, Kondo K, Nakashima C, Kida Y, Niwa T. Design of self-dispersible microsponge containing cyclosporine through wet milling and drop freeze-drying processes to improve dissolution behavior. J Drug Deliv Sci Technol. 2020;57:101577.","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11051-008-9357-4","article-title":"Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system","volume":"10","author":"Gao","year":"2008","unstructured":"10. Gao L, Zhang D, Chen M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J Nanopart Res. 2008;10:845-862.","journal-title":"J Nanopart Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12247-017-9287-8","article-title":"Lyophilized nanosuspensions for oral bioavailability \u0131mprovement of \u0131nsoluble drugs: preparation, characterization, and pharmacokinetic studies","volume":"12","author":"Zhang","year":"2017","unstructured":"11. Zhang H, Chen W, Zhao Z, Dong Q, Yin L, Zhou J, Ding Y. Lyophilized nanosuspensions for oral bioavailability \u0131mprovement of \u0131nsoluble drugs: preparation, characterization, and pharmacokinetic studies. J Pharm Innov. 2017;12:271-280.","journal-title":"J Pharm Innov"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11051-022-05403-9","article-title":"The technology for improving stability of nanosuspensions in drug delivery","volume":"24","author":"Guan","year":"2022","unstructured":"12. Guan W, Ma Y, Ding S, Liu Y, Song Z, Liu X, Tang L, Wang Y. The technology for improving stability of nanosuspensions in drug delivery. J Nanopart Res. 2022;24:14.","journal-title":"J Nanopart Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejps.2008.12.002","article-title":"Kinetic solubility and dissolution velocity of rutin nanocrystals","volume":"36","author":"Mauludin","year":"2009","unstructured":"13. Mauludin R, M\u00fcller RH, Keck CM. Kinetic solubility and dissolution velocity of rutin nanocrystals. Eur J Pharm Sci. 2009;36:502-510.","journal-title":"Eur J Pharm Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijpharm.2018.02.011","article-title":"Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling","volume":"540","author":"Medarevic","year":"2018","unstructured":"14. Medarevic D, Djuris J, Ibric S, Mitric M, Kachrimanis K. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling. Int J Pharm. 2018;540:150-161.","journal-title":"Int J Pharm"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s11051-013-2043-1","article-title":"Nanosuspensions of 10-hydroxycamptothecin that can maintain high and extended supersaturation to enhance oral absorption: preparation, characterization and in vitro\/in vivo evaluation","volume":"15","author":"Pu","year":"2013","unstructured":"15. Pu X, Sun J, Han J, Lian H, Zhang P, Yan Z, He Z. Nanosuspensions of 10-hydroxycamptothecin that can maintain high and extended supersaturation to enhance oral absorption: preparation, characterization and in vitro\/in vivo evaluation. J Nanopart Res. 2013;15:2043.","journal-title":"J Nanopart Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12247-020-09499-1","article-title":"Nanocrystals: characterization overview, applications in drug delivery, and their toxicity concerns","volume":"17","author":"Jahangir","year":"2022","unstructured":"16. Jahangir MA, Imam SS, Muheem A, Chettupalli A, Al-Abbasi FA, Nadeem MS, Kazmi I, Afzal M, Alshehri S. Nanocrystals: characterization overview, applications in drug delivery, and their toxicity concerns. J Pharm Innov. 2022;17:237-248.","journal-title":"J Pharm Innov"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12247-019-09413-4","article-title":"High pressure homogenizer in Pharmaceuticals: understanding \u0131ts critical processing parameters and applications","volume":"15","author":"KS","year":"2020","unstructured":"17. Yadav KS, Kale K. High pressure homogenizer in Pharmaceuticals: understanding \u0131ts critical processing parameters and applications. J Pharm Innov. 2020;15:690-701.","journal-title":"J Pharm Innov"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"106123","DOI":"10.1016\/j.ejps.2022.106123","article-title":"A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: development, optimization and in vivo evaluation","volume":"171","author":"G\u00fclba\u011f P\u0131nar","year":"2022","unstructured":"18. G\u00fclba\u011f P\u0131nar S, Canp\u0131nar H, Tan C, Celebi N. A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: development, optimization and in vivo evaluation. Eur J Pharm Sci. 2022;171:106123.","journal-title":"Eur J Pharm Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/10837450.2021.2020817","article-title":"Development of cyclosporine A nanosuspension: cytotoxicity and permeability on Caco-2 cell lines","volume":"27","author":"G\u00fclba\u011f P\u0131nar","year":"2021","unstructured":"19. G\u00fclba\u011f P\u0131nar S, Pezik E, Mutlu A\u011fardan N, Celebi N. Development of cyclosporine A nanosuspension: cytotoxicity and permeability on Caco-2 cell lines. Pharm Dev Technol. 2021;27:52-62.","journal-title":"Pharm Dev Technol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"101371","DOI":"10.1016\/j.jddst.2019.101371","article-title":"A wet-milling method for the preparation of cilnidipine nanosuspension with enhanced dissolution and oral bioavailability","volume":"55","author":"Liu","year":"2020","unstructured":"20. Liu Q, Mai Y, Gu X, Zhao Y, Di X, Ma X, Yang J. A wet-milling method for the preparation of cilnidipine nanosuspension with enhanced dissolution and oral bioavailability. J Drug Deliv Sci Technol. 2020;55:101371.","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jddst.2017.09.011","article-title":"Ziprasidone nanocrystals by wet media milling followed by spray drying and lyophilization: Formulation and process parameter optimization","volume":"43","author":"Koradia","year":"2018","unstructured":"21. Koradia KD, Sheth NR, Koradia HD, Dabhi MR. Ziprasidone nanocrystals by wet media milling followed by spray drying and lyophilization: Formulation and process parameter optimization. J Drug Deliv Sci Technol. 2018;43:73-84.","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jddst.2018.03.005","article-title":"Preparation and characterization of furosemide nanosuspensions","volume":"45","author":"Gulsun","year":"2018","unstructured":"22. Gulsun T, Borna SE, Vural I, Sahin S. Preparation and characterization of furosemide nanosuspensions. J Drug Deliv Sci Technol. 2018;45:93-100.","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejps.2016.05.010","article-title":"A Design of Experiment approach","volume":"95","author":"Karakucuk","year":"2016","unstructured":"23. Karakucuk A, Celebi N, Teksin ZS. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach. Eur J Pharm Sci. 2016;95:111-121.","journal-title":"Eur J Pharm Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejps.2019.02.028","article-title":"Evaluation of improved oral bioavailability of ritonavir nanosuspension","volume":"131","author":"Karakucuk","year":"2019","unstructured":"24. Karakucuk A, Teksin ZS, Eroglu H, Celebi N. Evaluation of improved oral bioavailability of ritonavir nanosuspension. Eur J Pharm Sci. 2019;131:153-158.","journal-title":"Eur J Pharm Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ejps.2018.07.009","article-title":"Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation","volume":"12","author":"Oktay","year":"2018","unstructured":"25. Oktay AN, Karakucuk A, Ilbasmis-Tamer S, Celebi N. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation. Eur J Pharm Sci. 2018;12:254-263.","journal-title":"Eur J Pharm Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jddst.2019.04.024","article-title":"Optimization and in vitro evaluation of ziprasidone nanosuspensions produced by a top-down approach","volume":"52","author":"Tashan","year":"2019","unstructured":"26. Tashan E, Karakucuk A, Celebi N. Optimization and in vitro evaluation of ziprasidone nanosuspensions produced by a top-down approach. J Drug Deliv Sci Technol. 2019;52:37-45.","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejps.2012.10.004","article-title":"Identifying the correlation between drug\/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology","volume":"48","author":"George","year":"2013","unstructured":"27. George M, Ghosh I. Identifying the correlation between drug\/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Eur J Pharm Sci. 2013;48:142-152.","journal-title":"Eur J Pharm Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"13053","DOI":"10.1039\/C6RA28676C","article-title":"Preparation and evaluation of celecoxib nanosuspensions for bioavailability enhancement","volume":"7","author":"He","year":"2017","unstructured":"28. He J, Han Y, Xu G, Yin L, Ngandeu Neubi M, Zhou J, Ding Y. Preparation and evaluation of celecoxib nanosuspensions for bioavailability enhancement. RSC Adv. 2017;7:13053-13064.","journal-title":"RSC Adv"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.drudis.2018.01.016","article-title":"Pharmaceutical nanocrystals: production by wet milling and applications","volume":"23","author":"Malamatari","year":"2018","unstructured":"29. Malamatari M, Taylor KMG, Malamataris S, Douroumis D, Kachrimanis K. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discov Today. 2018;23:534-547.","journal-title":"Drug Discov Today"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/03639045.2017.1291672","article-title":"Design of experiments (DoE) in pharmaceutical development","volume":"43","author":"Politis","year":"2017","unstructured":"30. Politis SN, Colombo P, Colombo G, Rekkas DM. Design of experiments (DoE) in pharmaceutical development. Drug Dev Ind Pharm. 2017;43:889-901.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1208\/s12249-013-9983-8","article-title":"Development and validation of a HPLC method for dissolution and stability assay of liquid-filled cyclosporine capsule drug products","volume":"14","author":"Xu","year":"2013","unstructured":"31. Xu X, Gupta A, Faustino P, Sathe PM, Sayeed VA, Khan MA. Development and validation of a HPLC method for dissolution and stability assay of liquid-filled cyclosporine capsule drug products. AAPS PharmSciTech. 2013;14:959-967.","journal-title":"AAPS PharmSciTech"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/jps.24266","article-title":"Systematic screening of different surface modifiers for the production of physically stable nanosuspensions","volume":"104","author":"MLAD","year":"2015","unstructured":"32. Lestari MLAD, M\u00fcller RH, M\u00f6schwitzer JP. Systematic screening of different surface modifiers for the production of physically stable nanosuspensions. J Pharm Sci. 2015;104:1128-1140.","journal-title":"J Pharm Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejps.2012.04.020","article-title":"Application of spray granulation for conversion of a nanosuspension into a dry powder form","volume":"47","author":"Bose","year":"2012","unstructured":"33. Bose S, Schenck D, Ghosh I, Hollywood A, Maulit E, Ruegger C. Application of spray granulation for conversion of a nanosuspension into a dry powder form. Eur J Pharm Sci. 2012;47:35-43.","journal-title":"Eur J Pharm Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3109\/03639045.2014.914528","article-title":"Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation","volume":"41","author":"Sun","year":"2015","unstructured":"34. Sun W, Ni R, Zhang X, Li LC, Mao S. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation. Drug Dev Ind Pharm. 2015;41:927-933.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Wang Y, Li X, Wang L, Xu Y, Cheng X, Wei P. Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery. Int J Nanomed. 2011;6:1497-1507.","DOI":"10.2147\/IJN.S21097"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"118630","DOI":"10.1016\/j.ijpharm.2019.118630","article-title":"Cyclosporine a-loaded UniORV(R): Pharmacokinetic and safety characterization","volume":"570","author":"Iyama","year":"2019","unstructured":"36. Iyama Y, Mineda M, Sei S, Hirasawa W, Matahira Y, Seto Y, Sato H, Onoue S. Cyclosporine a-loaded UniORV(R): Pharmacokinetic and safety characterization. Int J Pharm. 2019;570:118630.","journal-title":"Int J Pharm"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.08.010","article-title":"Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former","volume":"420","author":"Yamasaki","year":"2011","unstructured":"37. Yamasaki K, Kwok PC, Fukushige K, Prud'homme RK, Chan HK. Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former. Int J Pharm. 2011;420:34-42.","journal-title":"Int J Pharm"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.powtec.2015.05.012","article-title":"Amorphous formulations for dissolution and bioavailability enhancement of poorly soluble APIs","volume":"285","author":"Kanaujia","year":"2015","unstructured":"38. Kanaujia P, Poovizhi P, Ng WK, Tan RBH. Amorphous formulations for dissolution and bioavailability enhancement of poorly soluble APIs. Powder Technol. 2015;285:2-15.","journal-title":"Powder Technol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/jps.20523","article-title":"Quantitative determination of amorphous cyclosporine in crystalline cyclosporine samples by Fourier transform infrared spectroscopy","volume":"95","author":"Bertacche","year":"2006","unstructured":"39. Bertacche V, Pini E, Stradi R, Stratta F. Quantitative determination of amorphous cyclosporine in crystalline cyclosporine samples by Fourier transform infrared spectroscopy. J Pharm Sci. 2006;95:159-166.","journal-title":"J Pharm Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsps.2015.03.008","article-title":"Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology","volume":"24","author":"Attari","year":"2016","unstructured":"40. Attari Z, Bhandari A, Jagadish PC, Lewis S. Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology. Saudi Pharm J. 2016;24:57-63.","journal-title":"Saudi Pharm J"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","article-title":"Stability of nanosuspensions in drug delivery","volume":"172","author":"Wang","year":"2013","unstructured":"41. Wang Y, Zheng Y, Zhang L, Wang Q, Zhang D. Stability of nanosuspensions in drug delivery. J Control Release. 2013;172:1126-1141.","journal-title":"J Control Release"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2011.01.007","article-title":"State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery","volume":"78","author":"M\u00fcller","year":"2011","unstructured":"42. M\u00fcller RH, Gohla S, Keck CM. State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm. 2011;78:1-9.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejpb.2018.06.022","article-title":"Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method","volume":"130","author":"Huang","year":"2018","unstructured":"43. Huang S, Zhang Q, Li H, Sun Y, Cheng G, Zou M, Piao H. Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method. Eur J Pharm Biopharm. 2018;130:108-114.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijpharm.2013.10.038","article-title":"Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions","volume":"460","author":"Li","year":"2014","unstructured":"44. Li W, Quan P, Zhang Y, Cheng J, Liu J, Cun D, Xiang R, Fang L. Influence of drug physicochemical properties on absorption of water insoluble drug nanosuspensions. Int J Pharm. 2014;460:13-23.","journal-title":"Int J Pharm"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejpb.2018.09.022","article-title":"Jejunal absorption of aprepitant from nanosuspensions: Role of particle size, prandial state and mucus layer","volume":"132","author":"Roos","year":"2018","unstructured":"45. Roos C, Dahlgren D, Sj\u00f6gren E, Sj\u00f6blom M, Hedeland M, Lennern\u00e4s H. Jejunal absorption of aprepitant from nanosuspensions: Role of particle size, prandial state and mucus layer. Eur J Pharm Biopharm. 2018;132:222-230.","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T07:21:53Z","timestamp":1732260113000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjps.org\/articles\/doi\/tjps.galenos.2023.68054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":45,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2023,12,25]]},"published-print":{"date-parts":[[2023,12,25]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2023.68054","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"value":"1304-530X","type":"print"},{"value":"2148-6247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,25]]}}}